Zweig-DiMenna Associates’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Zweig-DiMenna Associates’s Portfolio SLGC Stock Details SLGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-588,218	Closed	-$1.49M	–	130
2023 Q4	$1.49M	Sell	588,218 -40,000	-6%	-$93.2K	0.17%	90
2023 Q3	$1.5M	Sell	628,218 -240,000	-28%	-$531K	0.18%	94
2023 Q2	$2.01M	Sell	868,218 -400,000	-32%	-$1.13M	0.25%	84
2023 Q1	$3.23M	Sell	1,268,218 -122,500	-9%	-$351K	0.44%	71
2022 Q4	$3.49M	Buy	1,390,718 +28,000	+2%	+$78.1K	0.51%	67
2022 Q3	$3.95M	Buy	1,362,718 +39,218	+3%	+$165K	0.86%	45
2022 Q2	$5.98M	Buy	1,323,500 +173,900	+15%	+$1.03M	1.14%	34
2022 Q1	$9.22M	Buy	1,149,600 +115,000	+11%	+$1.01M	1.23%	29
2021 Q4	$12M	Buy	1,034,600 +728,110	+238%	+$8.72M	0.97%	44
2021 Q3	$3.8M	Buy	306,490 +135,333	+79%	+$1.53M	0.26%	100
2021 Q2	$2.1M	Buy	+171,157	New	+$2.1M	0.13%	131

Zweig-DiMenna Associates's SLGC Position: Q1 2024 in Review

Zweig-DiMenna Associates sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 588,218 shares — an estimated $1.49M sold.

Zweig-DiMenna Associates first reported a position in SLGC in Q2 2021 and held it in 11 quarters. The position peaked at $12M in Q4 2021. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

Zweig-DiMenna Associates reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
Zweig-DiMenna Associates sold 588,218 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $1.49M.
Zweig-DiMenna Associates first reported a position in SomaLogic, Inc. Class A Common Stock in Q2 2021 and held it in 11 quarters.
Zweig-DiMenna Associates's SomaLogic, Inc. Class A Common Stock position peaked at $12M in Q4 2021.
0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on Zweig-DiMenna Associates's 13F filing for Q1 2024, filed 29 Apr 2024.